Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Suits me if this thing trades sideways for a couple more weeks. I want to buy more.
Not again! ??
Good place to start. Lets have another Atrain.
Well, support held for today. But lest I sound arrogant, supports, like resistances, are made to be broken. Cross your fingers until we get news.
I called that bottom in the 60s. I say we settle down and get several months of 25 - 30% days.
Looking back, we spent a month trading sideways in November / December. I think that was the bottom.
I've got two more MJ plays as well. This one will be good. I think they popped this ambiguous CEO change now to avoid killing a bigger run later.
The afternoon will tell us a lot about the short term.
Strong area of support in the low 60s on that chart.
Exactly, this whole chiropractor deal is an obvious misdirection play.
And what is our product line? Do we sell marijuana? No.
We aren't in the prescription medicine business. Relax.
I'm betting that the trading pattern holds and that we move up in the afternoon.
It's a better looking team than GRCU. Adults are taking control.
Vertical integration. Which is exactly what I suggested was needed here this morning.
Reverse Merger? Looks to me like the doctor wanted a way to take his company public. Will we see a reverse merger here as a quick way to avoid the endless paperwork and fees to do an IPO?
Boy, this is tiresome
Time for GRCU to think about doing some vertical integration. We need to put in a grow house (big one) in Colorado and open some straight MJ stores there.
Depending on another poster that 300M shares had been retired. I will say that the amount of the float in strong hands is much larger as well.
GRCU Weekly Chart
Smart traders work off the weekly chart.
RSI is a 58.1. Par SAR has flipped. Stochastics are beautiful and in a beautiful position.
For the longs, if we have a run similar to last spring? GRCU goes over $2. That will take a lot of volume but not as much as last time. The float is much smaller from what I understand.
That is the first thing that went through my mind when I saw Clay. Red day Monday. And I been waiting for an entry point. I will jump in.
Except for your tone I actually agree with this post. We need to hear about a partnership with a company that can actually take this through the process and to market.
I've been communicating with Casey. Green knows what we need to know.
Who is Garry Green?
The chart looks all mathematical and scientific and in ways it is BUT mainly it is a measure of the group mentality of the people that trade stocks. It's psychology.
By dropping the close with some questionable T trade action, the market makers increased the likelihood of a gap up in the morning.
And that will confirm the 50 day as support.
Resistances at 7, 10, 12, and 15. We can blow through all those with some volume.
So? If GRCU opens at .0062 tomorrow and goes up from there? There will be a gap on the chart? And gaps gotta fill? Right?
TCEL has the rights to a patent for use in the US. If they don't do anything but partner with another company to get it past the FDA and to the market? The company is worth $100M. That's probably where this should go.
Bro, have you ever posted any that was both accurate and from the last three months?
Just so y'all know, this is real.
http://www.horsetalk.co.nz/news/2012/03/017.shtml#axzz3OFyakj00
Follow us: @HorsetalkNZ on Twitter | Horsetalk on Facebook
Revolutionary science restores horse's Olympic hopes
March 2, 2012
Two years ago, Angelli, a grand prix showjumping horse from Southern California, was facing retirement or, at worst, euthanasia. His career as a contender for the 2012 Olympic Games was in tatters.
Harley Brown and Angelli.
Just the previous weekend, he and his international rider and trainer, Harley Brown of Australia, had been unable to compete in a major Californian show, as the previously grand prix level show jumper could not clear even the lowest of jumps.
Then a phone call was made to an internationally recognised veterinarian and scientist who travels the world as a consultant from New Zealand.
Three days later, Dr Patrick Casey arrived with his ultrasound machine and, after examining Angelli, gave Harley the heartbreaking news.
"He's torn his hind tendon badly, sort of shredded it," Casey explained.
Tendon injuries can be career-ending for horses - only 5 to 15 per cent of those with damaged tendons ever make it back to competition.
Casey explained a revolutionary tendon treatment that had already been shown to get 85 per cent of horses with torn tendons back to full competition.
It involves taking about 100 tendon cells from the injured horse without causing any harm to the animal.
Using a patented procedure, 20 to 40 million tendon cells are then grown in an incubator and transplanted back to the site of injury.
Brown and Angelli's owner, Mark Harryman, knew that unless they had a go, all hope was lost for their horse's future jumping career.
The treatment worked. Not only is Angelli's shredded tendon healed, but he has a chance to be selected to jump at the London Olympics for Australia with Harley Brown.
"We just could not have ever imagined how well this science works," Brown said.
"I have never heard of a horse coming back from this injury, let alone being competitive at the highest level. It's just like a dream."
Late in March, Casey, Brown and Harryman will be reunited in Wellington, Florida, where Angelli's American preparation will end and he will fly to Europe for more pre-Olympic trials.
It is fair to say that Dr Casey "wouldn't miss it for the world and, considering where I come from, wouldn't mind a cold one to celebrate."
Last year, Casey set up a public company in the United States called Therapy Cells, Inc.
It holds the exclusive technology that allows adult cells from a specific tissue, such as an Achilles tendon, to grow again from individual cells, to enact repair and regeneration of that tissue, effectively bypassing the need for stem cell treatment.
The company has developed a novel and highly efficient method of growing tendons and articular cartilage for auto transplantation into injured horses or people.
Any kind of buying pressure will send this to copper. Time for the company to step up.
There will be a few but when this thing gets close to .02 I'm going to take profits. We can reevaluate again at that time. Traders that are successful long term take profits.
In my very first penny I treated it like a big board stick. Rode it from .008 to .3545 I was convinced it was going to $1. Ended up selling at .04. Never again.
Nobody will still be here when Q1 numbers are reported. Penny stocks are for trading.
And the bid keeps building and inching up. . . .
The answer is somewhere between BKRT and CDEL
The bid is enormous